Photo Gallery     |     Video Gallery

Intellectual Properties/Patents

Patents Accepted

    1. A US and Canadian patent entitled: ”Broad-spectrum antibacterial activity of novel Bis-benzimidazole targeting topoisomerase IA” has been recently accepted on Date 05/03/2022 and 25/04/2022 respectively.
    2. A Canadian patent entitled: “DMA, a bis-benzimidazole, confers radioprotection to the intestine via AKT/NFKB dual pathway activation” has been accepted on 09/02/2022. 
    3. A USA Patent Granted on Filing No: 15/220631 Title: “DMA, a bis-benzimidazole, confers radioprotection to the intestine via AKT/NFKB dual pathway activation”
      Date of Filing- 2016/06/27 Date of Grant: 2018/05/01
    4. Indian Patent No: 217681 Patent application No 21/DEL/2003 Title: “A process of preparing an extract of Annona squamosa for treatment of diabetes.
      Date of Filing- 07/01/2003. Date of Grant-28/03/2008
    5. Indian Patent No: 241650 Patent application No. 32/DEL/2003. Title: “The process for the synthesis of bisbenzimidazoles and its”
      Date of Filing-09/01/2003 Date of Grant-17/07/2010
    6. European Patent No: 1590332 (European patent application no. 03815133.8) (Priority Indian patent application No 32/DEL/2003 and PCT International patent application no. PCT/IN03/00301) Title: “The process for the synthesis of bisbenzimidazoles and its ” Date of Filing: 08.09.2003. Date of Grant: April 27, 2011
    7. European Patent No: 1589983 (European patent application 03814526.4) (Priority Indian patent application No 21/DEL/2003 and PCT International Patent Application no. PCT/IN03/00228) Title: “A process of preparing an extract of Annona squamosa for treatment of diabetes”.
      Date of Filing: 20.06.2003 Date of grant: (EPO intention to grant issued, further pursuance would subject to the quick possibility of commercialization).

Patents Filed in recent Years (2016 -18)

1. PCT Application Filing No: PCT/IN2017/000013 Title: “Broad-spectrum antibacterial activity of novel Bis-benzimidazole targeting topoisomerase IA and synergistic composition of Bis-benzimidazole with efflux pump inhibitors against pathogenic bacteria”; Date of Filing: 20/01/2017, RO/IN (Delhi).
Filed in India Application no. 201611002627; Date of Filing: 23/01/2016, Delhi.

2. Indian Patent Filing No:201611008163 Title: “Novel Malonyl and dioxolan derivatives of indole as HIV-I integrase strand transfer inhibitors”; Date of Filing:2016/03/09.